potassium chloride- potassium chloride capsule, extended release

国: アメリカ合衆国

言語: 英語

ソース: NLM (National Library of Medicine)

有効成分:

Potassium Chloride (UNII: 660YQ98I10) (Potassium ion - UNII:295O53K152)

から入手可能:

ETHEX

INN（国際名）:

potassium chloride

医薬品形態:

CAPSULE, EXTENDED RELEASE

構図:

750 mg

投与経路:

ORAL

処方タイプ:

PRESCRIPTION DRUG

適応症:

BECAUSE OF REPORTS OF INTESTINAL AND GASTRIC ULCERATION AND BLEEDING WITH CONTROLLED-RELEASE POTASSIUM CHLORIDE PREPARATIONS, THESE DRUGS SHOULD BE RESERVED FOR THOSE PATIENTS WHO CANNOT TOLERATE OR REFUSE TO TAKE LIQUID OR EFFERVESCENT POTASSIUM PREPARATIONS OR FOR PATIENTS IN WHOM THERE IS A PROBLEM OF COMPLIANCE WITH THESE PREPARATIONS. - For the treatment of patients with hypokalemia, with or without metabolic alkalosis, in digitalis intoxications, and in patients with hypokalemic familial periodic paralysis. If hypokalemia is the result of diuretic therapy, consideration should be given to the use of a lower dose of diuretic, which may be sufficient without leading to hypokalemia. - For the prevention of hypokalemia in patients who would be at particular risk if hypokalemia were to develop, e.g., digitalized patients or patients with significant cardiac arrhythmias, hepatic cirrhosis with ascites, states of aldosterone excess with normal renal function, potassium-losing nephropathy, and certain diarrhe

製品概要:

Potassium chloride extended-release capsules, USP, 10 mEq (750 mg) are Clear hard gelatin capsules, imprinted "ETHEX" and "001", packaged as follows: NDC 58177-001-04 bottle of 100 Capsules NDC 58177-001-08 bottle of 500 Capsules NDC 58177-001-09 bottle of 1000 Capsules NDC 58177-001-11 Unit dose packages of 100 capsules Store at controlled room temperature 15° - 30°C (59° - 86°F). Dispense in tight container. Manufactured by KV Pharmaceutical Co. for ETHEX Corporation St. Louis, MO  63044

製品の特徴

POTASSIUM CHLORIDE- POTASSIUM CHLORIDE CAPSULE, EXTENDED RELEASE
ETHEX
----------
DESCRIPTION
Potassium chloride extended-release capsules, USP is an oral dosage
form of microencapsulated
potassium chloride containing 750 mg of potassium chloride, USP,
equivalent to 10 mEq of potassium.
Dispersibility of potassium chloride (KCl) is accomplished by
microencapsulation and a dispersing
agent. The resultant flow characteristics of the KCl microcapsules and
the controlled release of K
ions by the microcapsular membrane are intended to avoid the
possibility that excessive amounts of KCl
can be localized at any point on the mucosa of the gastrointestinal
tract.
Each crystal of KCl is microencapsulated by a patented process with an
insoluble polymeric coating
which functions as a semi-permeable membrane; it allows for the
controlled release of potassium and
chloride ions over an eight- to ten-hour period. Fluids pass through
the membrane and gradually
dissolve the potassium chloride within the microcapsules. The
resulting potassium chloride solution
slowly diffuses outward through the membrane. Potassium chloride
extended-release capsules, USP
are electrolyte replenishers. The chemical name of the active
ingredient is potassium chloride and the
structural formula is KCl. Potassium chloride, USP, occurs as a white
granular powder or as colorless
crystals. It is odorless and has a saline taste. Its solutions are
neutral to litmus. It is freely soluble in
water and insoluble in alcohol.
INACTIVE INGREDIENTS
Calcium stearate, gelatin, isopropyl alcohol, pharmaceutical glaze,
povidone, sugar spheres, and talc.
CLINICAL PHARMACOLOGY
Potassium ion is the principal intracellular cation of most body
tissues. Potassium ions participate in a
number of essential physiological processes, including the maintenance
of intracellular tonicity; the
transmission of nerve impulses; the contraction of cardiac, skeletal
and smooth muscle; and the
maintenance of normal renal function.
The intracellular concentration of potassium is approximate